Trials / Completed
CompletedNCT05964166
Tetragraph® Monitor: Tolerance of Preoperative Placement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Joseph D. Tobias · Academic / Other
- Sex
- All
- Age
- 3 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, non-blinded, single arm study. The primary objective of this study is to evaluate the tolerance to preoperative placement of the adhesive sensor for the Tetragraph® Neuromuscular Transmission Monitor in pediatric-sized patients ≤ 12 years of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TetraGraph NMT Monitor | TetraGraph is a unique, EMG=based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block. |
Timeline
- Start date
- 2023-05-31
- Primary completion
- 2023-08-01
- Completion
- 2023-08-01
- First posted
- 2023-07-27
- Last updated
- 2024-11-18
- Results posted
- 2024-09-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05964166. Inclusion in this directory is not an endorsement.